Verified factor-similar pair

ISCB vs NUSC

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
90
Near substitute

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • ISCB has the lower published fee (0.04% vs 0.31%).
  • ISCB is cheaper on dividend valuation (102 vs 303, where 100 is each fund's historical median).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

ISCB

iShares Morningstar Small-Cap ETF
SMB
Adj. R2
0.972
Rel. Sharpe
0.793
Mkt beta
1.02
AUM
US$261M
MER
0.04%
Valuation
102

NUSC

Nuveen ESG Small-Cap ETF
SMB
Adj. R2
0.971
Rel. Sharpe
0.789
Mkt beta
1.00
AUM
US$1.3B
MER
0.31%
Valuation
303

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
ISCB
+0.74
|t|
+28.2
NUSC
+0.75
|t|
+18.5
diff -0.00
HML
ISCB
+0.14
|t|
+5.3
NUSC
+0.13
|t|
+3.7
diff +0.01
RMW
ISCB
+0.03
|t|
+1.0
NUSC
-0.01
|t|
-0.2
diff +0.04
CMA
ISCB
-0.02
|t|
-0.4
NUSC
+0.01
|t|
+0.2
diff -0.03
UMD
ISCB
-0.03
|t|
-1.7
NUSC
+0.05
|t|
+1.6
diff -0.07

Why This Pair Matches

Exposure level
87
Exposure shape
100
Mkt beta diff
0.02
Rel. Sharpe diff
0.004

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

ISCB fund page NUSC fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.